ConductScience.org, home

Paper3045692

Autoimmune paraneoplastic cerebellar degeneration: ultrastructural localization of antibody-binding sites in Purkinje cells.

Rodriguez M and 3 others. Neurology, 1988. Cited by 83 papers, by iCite.

Cite this record

ConductScience Library. Autoimmune paraneoplastic cerebellar degeneration: ultrastructural localization of antibody-binding sites in Purkinje cells. Papers, record 3045692. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3045692

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Autoimmune paraneoplastic cerebellar degeneration: ultrastructural localization of antibody-binding sites in Purkinje cells.
PubMed
Journal
Neurology
PubMed
Year
1988
PubMed
Publication types
Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
83
iCite
Relative citation ratio, by iCite
2.29
iCite
Revised in PubMed
2019-05-14
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rodriguez MM
2Truh LIL I
3O'Neill BPB P
4Lennon VAV A

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Autoimmune DiseasesMajor topic
Cerebellar DiseasesMajor topic
Paraneoplastic SyndromesMajor topic
Purkinje CellsMajor topic
Aged
Binding Sites
Female
Fluorescent Antibody Technique
Humans

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA-37343NCI NIH HHSUnited StatesR01CA037343PubMed and NIHNIH RePORTER
NS-849NINDS NIH HHSUnited StatesPubMedPubMed

Download CSV of grants

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 83 citations.

PMIDTitleJournalYearIn PapersSource
40637585CDR2 is a dynein adaptor recruited by kinectin to regulate ER sheet organization.J Cell Biol2025https://conductscience.org/library/papers/40637585PubMed
39119541Paraneoplastic neurological syndromes of small cell lung cancer.Postep Psychiatr Neurol2024https://conductscience.org/library/papers/39119541PubMed
38802745Multi-omics profiling reveals dysregulated ribosome biogenesis and impaired cell proliferation following knockout of CDR2L.BMC Cancer2024https://conductscience.org/library/papers/38802745PubMed
38510211Cerebellar degeneration in gluten ataxia is linked to microglial activation.Brain Commun2024https://conductscience.org/library/papers/38510211PubMed
37239077Paraneoplastic Neurological Syndromes of the Central Nervous System: Pathophysiology, Diagnosis, and Treatment.Biomedicines2023https://conductscience.org/library/papers/37239077PubMed
35881322The Discovery of Anti-Yo (Anti-PCA1) Antibody in Patients with Paraneoplastic Cerebellar Degeneration: Opening a Window into Autoimmune Neurological Disease.Cerebellum2023https://conductscience.org/library/papers/35881322PubMed
35111121Paraneoplastic and Other Autoimmune Encephalitides: Antineuronal Antibodies, T Lymphocytes, and Questions of Pathogenesis.Front Neurol2021https://conductscience.org/library/papers/35111121PubMed
34277016Paraneoplastic neurological syndrome: an evolving story.Neurooncol Pract2021https://conductscience.org/library/papers/34277016PubMed
33009713Localization of CDR2L and CDR2 in paraneoplastic cerebellar degeneration.Ann Clin Transl Neurol2020https://conductscience.org/library/papers/33009713PubMed
29930189Paraneoplastic cerebellar degeneration with bilateral facial palsy: a rare primary presentation of breast cancer.BMJ Case Rep2018https://conductscience.org/library/papers/29930189PubMed
29679372Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium buffering capacity.Neuropathol Appl Neurobiol2019https://conductscience.org/library/papers/29679372PubMed
27606347Paraneoplastic cerebellar degeneration with anti-Yo antibodies - a review.Ann Clin Transl Neurol2016https://conductscience.org/library/papers/27606347PubMed
26561982Signal recognition particle immunoglobulin g detected incidentally associates with autoimmune myopathy.Muscle Nerve2016https://conductscience.org/library/papers/26561982PubMed
26377319
'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.
J Neuroinflammation2015https://conductscience.org/library/papers/26377319PubMed
25885452
Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers.
PLoS One2015https://conductscience.org/library/papers/25885452PubMed
25341622Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis.Acta Neuropathol2014https://conductscience.org/library/papers/25341622PubMed
24167748Anti-yo associated paraneoplastic cerebellar degeneration in a man with large cell cancer of the lung.Case Rep Neurol Med2013https://conductscience.org/library/papers/24167748PubMed
22934121Anti-purkinje cell and natural autoantibodies in a group of psychiatric patients. Evidences for a correlation with the psychopathological status.Clin Pract Epidemiol Ment Health2012https://conductscience.org/library/papers/22934121PubMed
20838245Purkinje cell death after uptake of anti-Yo antibodies in cerebellar slice cultures.J Neuropathol Exp Neurol2010https://conductscience.org/library/papers/20838245PubMed
10219744Autoimmunity in paraneoplastic neurological syndromes.Brain Pathol1999https://conductscience.org/library/papers/10219744PubMed

See all 27 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3045692

GET https://conductscience.org/api/papers/v1/3045692/cited_by?page=2